CRH Launches $1B Exchange Offer for Arcosa Notes

CRH America Finance, Inc. launched cash tender offers and exchange offers on 4 November 2026 for two series of Arcosa, Inc. senior notes, alongside consent solicitations to strip covenants from the underlying indentures. The offers target $400 million of 4.375% notes due 2029 and $600 million of 6.875% notes due 2032, with early tender consideration of $983.75 and $1,035.00 per $1,000 principal respectively. Both series carry an early premium of $50 per $1,000. The exchange leg caps new CRH AF guaranteed notes at $1 billion.

Context — why the Arcosa note offers matter now

CRH plc closed its acquisition of Arcosa on 23 October 2026, making Arcosa an indirect wholly owned subsidiary. The tender and exchange offers are the financing cleanup that follows. Arcosa notes that are accepted and purchased or exchanged will be cancelled and will no longer remain outstanding obligations of Arcosa, the company said.

That matters because Arcosa paper now sits inside a larger, higher-rated corporate family. CRH AF is an indirect wholly owned subsidiary of CRH plc, and the new notes it proposes to issue would be fully and unconditionally guaranteed by CRH plc. Holders are effectively being asked to swap Arcosa credit risk for CRH group credit risk, with the same coupon and maturity.

The consent solicitations run in parallel. Arcosa is asking holders to approve amendments that would eliminate certain covenants, restrictive provisions, events of default and guarantee provisions in the existing indentures. The company did not disclose the specific clauses targeted beyond those categories.

A holder can only tender a given note into either the cash tender or, if eligible, the exchange offer. Consents cannot be delivered without tendering notes of the applicable series into the corresponding offer. Tendering a note is deemed to deliver a consent for that principal amount.

The catalyst chain is straightforward: acquisition close, then liability management, then covenant stripping once the consent threshold is met. The report does not state the consent threshold figure.

Data — what the numbers show

For each $1,000 principal of Arcosa notes accepted, holders receive the following under the cash tender offers:

Series	Principal outstanding	Tender consideration	Total with early premium
4.375% notes due 2029	$400,000,000	$933.75	$983.75
6.875% notes due 2032	$600,000,000	$985.00	$1,035.00

Accrued and unpaid interest is paid on top of both figures, from the last interest payment date to, but excluding, the settlement date.

The exchange offers carry different math. Eligible holders tendering at or before the early date receive $1,000 principal of new CRH AF notes per $1,000 of Arcosa notes. Tendering after the early date but before expiration yields $950 principal of new paper per $1,000.

The new notes mirror the old ones: same maturity, same interest rate, same payment dates, plus registration rights. The exchange offer is capped at $1,000,000,000 aggregate principal of new CRH AF notes, against $1,000,000,000 of Arcosa notes outstanding across both series.

Timing is tight. The early tender deadline and withdrawal deadline both fall at 5:00 p.m. New York City time on 18 November 2026. Expiration is 5:00 p.m. on 4 December 2026. Early settlement is expected 20 November, final settlement 8 December.

Analysis — what it means for bond and credit markets

The economics favour early action. A holder tendering the 2029 notes early captures $983.75 in cash against $933.75 later, a $50 gap. On the 2032s the gap is identical at $50. In the exchange, the early window is worth $50 of extra principal per $1,000, since late tenders receive $950 rather than $1,000.

For a holder choosing between cash and exchange, the exchange preserves coupon and maturity while substituting CRH plc-backed credit. The cash route monetises the position outright. The report does not disclose pricing on the concurrent notes offering that funds the cash leg.

The consent mechanics carry a one-way ratchet. Once supplemental indentures are executed, a later withdrawal of a tender will not revoke a previously delivered consent, even where withdrawal rights remain available. The amendments become operative only once CRH AF purchases or exchanges all validly tendered notes of that series.

The main limitation is conditionality. CRH AF's obligation to buy is conditioned on receiving enough gross proceeds from the concurrent senior notes offering to fund the tender consideration, on or before the early settlement date, on terms it deems acceptable in its sole discretion. CRH AF reserves the right to extend, terminate, amend or waive conditions on either offer at any time. Any change to a tender or exchange offer automatically flows through to the corresponding consent solicitation.

Positioning skews toward participation. The early premium exists to pull holders off the fence before 18 November, and the consent threshold can be met by tenders across either offer or both combined. Credit desks holding Arcosa paper face a decision before that date, not at December expiration.

Outlook — what to watch next

The first hard date is 18 November 2026, when the early tender and withdrawal deadlines pass at 5:00 p.m. New York City time. Participation levels by then determine whether the consent thresholds are met and whether an early settlement on 20 November proceeds.

The second is 4 December 2026, the expiration date for both offers and the consent solicitations. If CRH AF has not secured sufficient concurrent offering proceeds by the early settlement date, the company has said it is under no obligation to run an early settlement and would pay on the final settlement date instead.

Watch the concurrent notes offering. Its size and pricing are the funding condition for the entire cash tender leg, and the report does not give either figure. Also watch for supplemental indentures being executed after the withdrawal deadline, which would lock in delivered consents.

Frequently Asked Questions

What happens to Arcosa notes that are not tendered?

Notes that are not validly tendered and accepted stay outstanding as obligations of Arcosa, an indirect wholly owned subsidiary of CRH plc following the 23 October 2026 acquisition. The report does not state any intention to redeem or otherwise retire non-tendered notes. Holders who sit out retain their existing coupon, maturity and the covenants in the current indentures, unless the proposed amendments become operative for that series.

Can I tender into both the cash and exchange offers?

No. A holder of Arcosa notes can only tender specific notes into either the applicable cash tender offer or, if that holder qualifies as an Eligible Holder, the applicable exchange offer. The same restriction applies per note, not per holder, so a holder with positions in both series could direct one series to cash and the other to the exchange, subject to eligibility.

What makes a holder eligible for the exchange offers?

Eligibility requires certification under at least one of several categories: qualified institutional buyers in the United States under Rule 144A, non-U.S. persons in offshore transactions under Regulation S, or specified professional and accredited investor categories in the EEA, United Kingdom and Canada. Eligible holders must complete and return an eligibility certification before reviewing the offering memorandum or participating.

Bottom Line

Arcosa noteholders must decide by 18 November whether to take CRH-backed paper or cash plus a $50 early premium.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.